Navigation Links
Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
Date:10/16/2009

NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis

http://www.reportlinker.com/p0155124/Reportlinker-Adds-Global-Top-10-Biotechnology-Companies----Industry-Financial-and-SWOT-Analysis.html

Scope:

'Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players' is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.

The report includes the following:

- Industry analysis including market value, market volume, market share and forecast growth till 2012

- Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power

- SWOT and 5-year financial analysis of top 10 players in the industry

- Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months

The top 10 companies have been ascertained based on their global revenues for the financial year 2008.

Highlights:

The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007-12, which is expected to drive the market to a value of $275.8 billion by the end of 2012.

The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.

The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.

Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.

Reasons to Purchase

- Gain insights into the industry, leading companies and competitors through a single report

- Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data

- Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies

- Determine industry attractiveness from five-forces analysis of constituent segments.

TABLE OF CONTENTS

Executive Summary 7

Industry analysis 7

Industry definition 7

Research highlights 7

Top 10 companies landscape 8

Market Value 9

Market Forecast 10

Market Segmentation--Product 11

Market Segmentation--Geographic 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Substitutes 17

Rivalry 18

Top 10 Companies Landscape 19

Revenue analysis 23

Financial performance analysis 25

Company Reports 30

Amgen 30

Genentech 35

Gilead Sciences 40

Genzyme 49

Biogen Idec 54

Celgene 63

Cephalon 67

Actelion 71

Financial Analysis 75

Amgen 75

Genentech 78

Gilead Sciences 81

Genzyme 87

Biogen Idec 90

Celgene 96

Cephalon 99

Actelion 102

Appendix 105

FIGURES

Figure 1: Global biotechnology market, $ million, 2003-07 9

Figure 2: Global biotechnology market forecast, $ million, 2007-12 10

Figure 3: Global biotechnology market segmentation--product, % share, 2007 11

Figure 4: Global biotechnology market segmentation--geography, % share, 2007 12

Figure 5: Forces driving competition in the global biotechnology market 13

Figure 6: Drivers of buyer power in the global biotechnology market 14

Figure 7: Drivers of supplier power in the global biotechnology market 15

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market 16

Figure 9: Factors influencing the threat of substitutes in the global biotechnology market 17

Figure 10: Drivers of degree of rivalry in the global biotechnology market 18

Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008 20

Figure 12: Revenue growth of global top 10 biotechnology companies, 2006-08 24

Figure 13: Operating performance analysis, FY2008 26

Figure 14: Net profit analysis, FY2008 27

Table 1: Global biotechnology market, $ million, 2003-07 9

Table 2: Global biotechnology market forecast, $ million, 2007-12 10

Table 3: Global biotechnology market segmentation--product , % share, 2007 11

Table 4: Global biotechnology market segmentation--geography, % share, 2007 12

Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008 19

Table 6: Revenue growth of global top 10 biotechnology companies, 2006-08 23

Table 7: Key financials of global top 10 biotechnology companies, FY2008 25

Table 8: Key industry specific ratios, FY2008 28

Table 9: Amgen--Financial and operational highlights, 2004-08 ($ million) 75

Table 10: Amgen--Key industry specific ratios, 2004-2008 77

Table 11: Genentech--Financial and operational highlights, 2004-08 ($ million) 78

Table 12: Genentech--Key industry specific ratios, 2004-08 80

Table 13: Gilead Sciences--Financial and operational highlights, 2004-08 ($ million) 81

Table 14: Gilead Sciences--Key industry specific ratios, 2004-08 83

Table 19: UCB--Financial and operational highlights, 2004-08 ($ million) 84

Table 20: UCB--Key industry specific ratios, 2004-08 86

Table 15: Genzyme--Financial and operational highlights, 2004-08 ($ million) 87

Table 16: Genzyme--Key industry specific ratios, 2004-08 89

Table 17: Biogen Idec--Financial and operational highlights, 2004-08 ($ million) 90

Table 18: Biogen Idec--Key industry specific ratios, 2004-08 92

Table 21: CSL--Financial and operational highlights, 2004-08 ($ million) 93

Table 22: CSL--Key industry specific ratios, 2004-08 95

Table 23: Celgene-- Financial and operational highlights, 2004-08 ($ million) 96

Table 24: Celgene--Key industry specific ratios, 2004-08 98

Table 25: Cephalon--Financial and operational highlights, 2004-2008 ($ million) 99

Table 26: Cephalon--Key industry specific ratios, 2004-08 101

Table 27: Actelion--Financial and operational highlights, 2004-08 ($ million) 102

Table 28: Actelion--Key industry specific ratios, 2004-08 104

To order this report:

Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis

http://www.reportlinker.com/p0155124/Reportlinker-Adds-Global-Top-10-Biotechnology-Companies----Industry-Financial-and-SWOT-Analysis.html

More market research reports here!

    Contact:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Nanomedicine Report
5. Reportlinker Adds Small Molecule Kinase Inhibitors Report
6. Reportlinker Adds Nanoporous Materials Report
7. Reportlinker Adds Membrane Bioreactors Report
8. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
9. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Reportlinker Adds Stem Cell Therapeutics Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... 2016, to be held February 8-9, 2016, at the ... Disruptive Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/4/2016)... OXFORD, England , February 4, 2016 ... Advanced Bioscience Laboratories (ABL), Inc. --> Strasbourg, ... (ABL), Inc. --> PharmaVentures is pleased to announce ... sale of its biopharmaceutical manufacturing unit in Strasbourg, ... (ABL), Inc. --> --> ...
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases ... from Vigilant Solutions. Brian Wenberg explains, ... victim was walking out of a convenience store and witnessed an elderly male ... vehicle, striking his vehicle and leaving the scene.  In ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
(Date:2/1/2016)... Rising sales of consumer electronics ... intuitive gesture control market size ... consumer electronics coupled with new technological advancements to drive ... through 2020   --> ... advancements to drive global touchfree intuitive gesture control market ...
Breaking Biology News(10 mins):